Zacks: Brokerages Anticipate Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Will Announce Quarterly Sales of $87.77 Million
Analysts expect that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will post sales of $87.77 million for the current quarter, Zacks reports. Four analysts have made estimates for Harmony Biosciences’ earnings, with the highest sales estimate coming in at $88.80 million and the lowest estimate coming in at $86.88 million. Harmony Biosciences posted sales […]